Stockscreener 앱 받기
3.50
0.00%
0.00
시장 영업 전:
3.74
0.24
+6.86%
전일 마감가:
$3.50
열려 있는:
$3.47
하루 거래량:
196.30K
Relative Volume:
2.07
시가총액:
$90.76M
수익:
$40,000
순이익/손실:
$-38.64M
주가수익비율:
-1.9007
EPS:
-1.8414
순현금흐름:
$-22.21M
1주 성능:
+1.16%
1개월 성능:
-22.05%
6개월 성능:
-67.35%
1년 성능:
-26.93%
1일 변동 폭
$3.31
$3.61
1주일 범위
$3.31
$3.62
52주 변동 폭
$3.005
$12.99
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
명칭
Neonc Technologies Holdings Inc
전화
310 663 7831
주소
23975 PARK SORRENTO, CALABASAS
Compare NTHI vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
3.50 | 89.21M | 40,000 | -38.64M | -22.21M | -1.8414 |
VRTX
Vertex Pharmaceuticals Inc
|
523.91 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
808.05 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
866.11 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.97 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
359.00 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Neonc Technologies Holdings Inc Stock (NTHI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-05-19 | 개시 | Alliance Global Partners | Buy |
| 2026-05-18 | 개시 | Maxim Group | Buy |
| 2026-04-24 | 개시 | BTIG Research | Buy |
Neonc Technologies Holdings Inc 주식(NTHI)의 최신 뉴스
NTHI|NeOnc Technologies Holdings Inc|Price:3.430| - TradingKey
Neonc Technologies Holdings, Inc. Announces Appointment of Nasim Shomali to Board of Directors, Effective July 1, 2026 - marketscreener.com
NeOnc Technologies Holdings, Inc. Revenue Breakdown – NASDAQ:NTHI - TradingView
NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors - Asianet Newsable
NeOnc appoints Nasim Shomali to board of directors - Investing.com
NeOnc Technologies Holdings Appoints Nasim Shomali to Board of Directors - Quiver Quantitative
NeOnc appoints Nasim Shomali to board of directors By Investing.com - Investing.com Canada
Press Release: NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to Its Board of Directors - Moomoo
NeOnc Technologies Holdings Inc (NTHI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
NeOnc Technologies Holdings Inc - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NTHI|NeOnc Technologies Holdings Inc|Price:3.430|Chg%:-0.200 - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Institutional Confidence - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Cash Flow - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Balance Sheet - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Income Statement - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Valuation: PE, PB & Fair Value Analysis - TradingKey
NeOnc Technologies (NTHI) Shows Resilience with 1.68% Gain, Testing Key ResistanceDefined Outcome ETF - dars.gov.et
NeOnc Shares Rise on Abu Dhabi Approval for Brain-Cancer Drug Trial - Moomoo
Enterprise value to EBITDA forward of NeOnc Technologies Holdings, Inc. – NASDAQ:NTHI - TradingView
Enterprise value to EBIT forward of NeOnc Technologies Holdings, Inc. – NASDAQ:NTHI - TradingView
Enterprise value to revenue forward of NeOnc Technologies Holdings, Inc. – NASDAQ:NTHI - TradingView
Price to earnings forward of NeOnc Technologies Holdings, Inc. – BOATS:NTHI - TradingView
NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition - Sahm
Neonc TechnologiesCancels July 9 FDA Meeti - Moomoo
NEONC TECHNOLOGIESTO UPDATE NEO212 DEVELOPMENT PLAN AFTER INCORPORATING FDA FEEDBACK - Moomoo
NeOnc receives FDA feedback on NEO212 manufacturing requirements By Investing.com - Investing.com Nigeria
NeOnc receives FDA feedback on NEO212 manufacturing requirements - Investing.com India
NeOnc receives FDA CMC feedback on NEO212; capsule-to-tablet bioavailability study advised - TradingView
NeOnc Technologies (NASDAQ: NTHI) receives detailed FDA CMC feedback on NEO212 - Stock Titan
Bullish NeOnc Technologies Holdings Insider Buying Worth US$615.6k Yet To Pay Off - simplywall.st
RANI Stock Price and Chart — NASDAQ:RANI - TradingView
Form 4 Neonc Technologies Holdings Inc For: 13 July By Investing.com - Investing.com Nigeria
NEONC Technologies (NTHI) awards director 50,000 restricted shares - Stock Titan
Neonc Technologies (NTHI) director discloses holding 160 common shares - Stock Titan
NeOnc Technologies Holdings, Inc. (NTHI) 8-K Filing: Director and Officer Changes Announced – Nasdaq Emerging Growth Company Update – Minichart - Minichart
NeOnc Technologies Adds New Director Amid Governance Focus - TipRanks
New NeOnc (NASDAQ: NTHI) director is CEO's niece - Stock Titan
NeOnc Technologies Holdings, Inc. Financial Disclosures & SEC Filings - TradingView
NeOnc Technologies Holdings (NTHI) Investor Relations, Earnings Summary & Outlook - Quartr
NTHI Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues Investment PhaseNext Quarter Guidance - dars.gov.et
NeOnc Technologies Holdings, Inc. (NTHI) Stock Price, News, Quote & History - Yahoo! Finance Canada
NeOnc Technologies Holdings, Inc.(NasdaqGM:NTHI) dropped from Russell 3000E Growth Benchmark - marketscreener.com
NeOnc Technologies Holdings, Inc.(NasdaqGM:NTHI) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
NTHI Q1 2026 Earnings: EPS Misses Estimates as Company Focuses on Pipeline DevelopmentEarnings Expansion Phase - dars.gov.et
NTHI Forecast — Price Target — Prediction for 2027 - TradingView
NeOnc Technologies Holdings, Inc. Actuals & Estimates (NASDAQ:NTHI) - TradingView
Neonc Technologies Holdings Inc (NTHI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Neonc Technologies Holdings Inc 주식 (NTHI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Heshmatpour Amir F | President |
Apr 28 '26 |
Buy |
4.52 |
10,000 |
45,180 |
3,062,000 |
| Neman-Ebrahim Yousha | Chief Clinical Officer |
Apr 23 '26 |
Buy |
4.88 |
500 |
2,440 |
134,760 |
| Heshmatpour Amir F | President |
Apr 23 '26 |
Buy |
4.90 |
10,000 |
49,000 |
3,052,000 |
| SUH, DAVID JR. | Chief Accounting Officer |
Apr 09 '26 |
Buy |
5.00 |
200 |
1,000 |
111,866 |
| Heshmatpour Amir F | President |
Apr 10 '26 |
Buy |
4.89 |
10,000 |
48,950 |
3,042,000 |
| Heshmatpour Amir F | President |
Apr 08 '26 |
Buy |
5.61 |
10,000 |
56,050 |
3,027,000 |
| Heshmatpour Amir F | President |
Apr 09 '26 |
Buy |
5.19 |
5,000 |
25,950 |
3,032,000 |
| Heshmatpour Amir F | President |
Apr 02 '26 |
Buy |
6.09 |
20,000 |
121,798 |
3,012,000 |
| Heshmatpour Amir F | President |
Apr 06 '26 |
Buy |
6.32 |
5,000 |
31,600 |
3,017,000 |
| Heshmatpour Amir F | President |
Nov 21 '25 |
Buy |
6.07 |
24,000 |
145,600 |
2,986,000 |
0.82%
1.54%
자본화:
|
볼륨(24시간):